Posted on 2/18/21
Cogito Appoints Susan Carstensen to Board
BOSTON--(BUSINESS WIRE)--Cogito, the leader in AI Coaching Systems for the enterprise, today announced the appointment of its new board member, Susan Carstensen. With decades of experience . . .
Posted on 2/18/21
Craig Powell Appointed Chairman of Beat the Streets New England
Entrepreneur Craig Powell has been appointed as Chairman of the Board for non-profit Beat the Streets New England (BTSNE), a new coalition formed from the merger . . .
Posted on 2/18/21
Axius Water Appoints Two Industry Experts to Board of Directors
BOSTON--(BUSINESS WIRE)--Axius Water, the leading water quality solutions platform created by KKR and XPV Water Partners to address pressing water quality challenges across the globe, today . . .
Posted on 2/18/21
Entegris Appoints Yvette Kanouff and Rodney Clark to Board of Directors
Entegris, Inc. (NASDAQ: ENTG), a world-class supplier of advanced materials and process solutions for the semiconductor and other high-technology industries, today announced the appointment of two . . .
Posted on 2/18/21
Evolv Technology Appoints Merline Saintil to its Board of Directors
Evolv Technology, the world’s leading provider of artificial intelligence (AI)-based touchless security screening systems, today announced the appointment of digital transformation executive Merline Saintil
Posted on 2/18/21
Armored Things Appoints Tom Axbey to Board
Armored Things, the crowd intelligence software company, today announced the addition of tech entrepreneur and industry veteran Tom Axbey to its Board of Directors.
Posted on 2/18/21
Generation Bio Appoints Ron Cooper to Board
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, announced . . .
Posted on 2/17/21
Entegris Appoints Yvette Kanouff and Rodney Clark to Board
Entegris, Inc. (NASDAQ: ENTG), a world-class supplier of advanced materials and process solutions for the semiconductor
Posted on 2/17/21
Webster’s Philip Picillo Joins Nacha National Board of Directors
Webster Bank is pleased to announce that Philip Picillo, Head of Treasury & Payment Solutions, has been reappointed
Posted on 2/17/21
Susan Chapman-Hughes Joins Toast Board of Directors
Toast, the fastest-growing restaurant management platform, today announced that Susan Chapman-Hughes has been appointed to the company's board of directors, effective immediately.
Posted on 2/17/21
Abiomed Appoints Dr. Myron Rolle to Board
Abiomed (NASDAQ: ABMD) announces the appointment of Myron Rolle, MD, to the Abiomed Board of Directors, effective immediately. Dr. Rolle will serve as a member of . . .
Posted on 2/17/21
scPharmaceuticals Appoints William T. Abraham, M.D., to Board
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize
Posted on 2/16/21
Activ Surgical Appoints Prof. Dr. Rainer Kimmig to its European Advisory Board
Activ Surgical, a digital surgery pioneer, today announced the appointment of Prof. Dr. Rainer Kimmig to its European Advisory Board. Prof. Dr. Kimmig currently serves as . . .
Posted on 2/16/21
Dewpoint Therapeutics Appoints Regina Barzilay, Ph.D., to its Board of Directors
Dewpoint Therapeutics, the biomolecular condensates company, today announced that it has appointed Regina Barzilay, Ph.D., to its Board of Directors. Dr. Barzilay's work leverages artificial intelligence . . .
Posted on 2/16/21
FirstLight Power Appoints Stephan Rupert Board Chair
FirstLight Power, a leading clean power producer and energy storage company, today announced that the company has elected Stephan Rupert as Chair of its Board of . . .
Posted on 2/16/21
Aware Appoints Gary Evee to Board of Directors
Aware, Inc., (NASDAQ: AWRE), a leading global provider of biometrics software products, solutions and services, announced that the Aware Board of Directors has appointed Gary Evee . . .
Posted on 2/16/21
Evelo Biosciences Appoints John A. Hohneker, M.D. to Board of Directors
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced the appointment of John Hohneker, M.D.,
Posted on 2/16/21
Mark Einhorn Named to Board of Directors for South Shore Habitat for Humanity
South Shore Habitat for Humanity, which has delivered quality housing in partnership with families in need for the past
Posted on 2/12/21
Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies
Posted on 2/11/21
Cognex Chairman and Founder, Dr. Robert J. Shillman, to Resign
Cognex Corporation (NASDAQ: CGNX) today announced that after 40 incredible years, Dr. Robert J. Shillman
Posted on 2/11/21
Steven G. Auerbach Joins HPOne Board of Directors
HPOne, a leading sales and marketing organization operating across multiple segments of the Medicare and health insurance marketplaces, has announced that Steven G. Auerbach joined its . . .
Posted on 2/11/21
Niloofar Razi Howe Joins Tamr Board of Directors
Tamr, the leading provider of cloud-native data mastering solutions, today announced Niloofar Razi Howe has joined the company's Board of Directors. Howe brings 25+ years of . . .
Posted on 2/11/21
Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to Board of Directors
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the appointment of Philina Lee, Ph.D., as . . .
Posted on 2/11/21
SeaChange International Appoints Matthew Stecker to Board of Directors
SeaChange International, Inc. (NASDAQ: SEAC), a leading provider of video delivery platforms, today announced that its Board of Directors has appointed veteran technology executive Matthew Stecker . . .
Posted on 2/11/21
Surface Oncology to Appoint Robert Ross, M.D., as CEO
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation therapies targeting the tumor microenvironment, announced today that . . .
Boston
